604 related articles for article (PubMed ID: 26033230)
1. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
[TBL] [Abstract][Full Text] [Related]
2. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
[TBL] [Abstract][Full Text] [Related]
3. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
[TBL] [Abstract][Full Text] [Related]
4. [Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
Girard C; Adamski H; Basset-Séguin N; Beaulieu P; Dreno B; Riboulet JL; Lacour JP
Ann Dermatol Venereol; 2016 Apr; 143(4):257-63. PubMed ID: 27016200
[TBL] [Abstract][Full Text] [Related]
5. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
6. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
[TBL] [Abstract][Full Text] [Related]
7. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
[TBL] [Abstract][Full Text] [Related]
8. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
9. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
[TBL] [Abstract][Full Text] [Related]
10. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
[TBL] [Abstract][Full Text] [Related]
11. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
[TBL] [Abstract][Full Text] [Related]
12. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
13. Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus.
Morton CA; Wulf HC; Szeimies RM; Gilaberte Y; Basset-Seguin N; Sotiriou E; Piaserico S; Hunger RE; Baharlou S; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1718-23. PubMed ID: 25627399
[TBL] [Abstract][Full Text] [Related]
14. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
[TBL] [Abstract][Full Text] [Related]
15. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
[TBL] [Abstract][Full Text] [Related]
16. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
[TBL] [Abstract][Full Text] [Related]
17. Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial.
Heerfordt IM; Wulf HC
J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2058-2061. PubMed ID: 31197894
[TBL] [Abstract][Full Text] [Related]
18. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
[TBL] [Abstract][Full Text] [Related]
19. A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Wiegell SR; Fabricius S; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Jemec GB; Mogensen M; Brocks KM; Philipsen PA; Heydenreich J; Haedersdal M; Wulf HC
Br J Dermatol; 2011 May; 164(5):1083-90. PubMed ID: 21219287
[TBL] [Abstract][Full Text] [Related]
20. Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
Calzavara-Pinton P; Zane C; Pacou M; Szeimies RM
Eur J Dermatol; 2016 Oct; 26(5):487-492. PubMed ID: 27352420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
